LXEO
Lexeo Therapeutics, Inc. Common Stock$5.77+0.14 (+2.58%)Prev Close$5.63·MCap$433.4M·P/E—·Vol274.8K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
6
$488.3K
◆
Net Activity
Net Seller
$488.3K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Lexeo Therapeutics, Inc. Common Stock (LXEO) has been exclusively selling, with 0 insider purchases totaling $0.00 and 6 insider sales totaling $488.3K. The most recent insider transaction was by Townsend Richard Nolan (director, officer: Chief Executive Officer), who sold $313.1K worth of shares on Apr 7, 2026. Lexeo Therapeutics, Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $433.4M.
LXEO Insider Trading Activity
LXEO Insider Buying Activity
The following table shows recent insider purchases of Lexeo Therapeutics, Inc. Common Stock (LXEO) stock reported via SEC Form 4 filings.
LXEO Insider Selling Activity
The following table shows recent insider sales of Lexeo Therapeutics, Inc. Common Stock (LXEO) stock reported via SEC Form 4 filings.